Towards Cellular-Scale Interpretability in Pathology Foundation Models for Biomarker Assessment
面向生物标志物评估的病理基础模型中的细胞级可解释性
机构 * Institute of Pathology, Technical University of Munich(慕尼黑技术大学病理学研究所) ; School of Computation, Information and Technology, Technical University of Munich(慕尼黑技术大学计算、信息与技术学院) ; Munich Center for Machine Learning (MCML)(慕尼黑机器学习中心) ; Computer Aided Medical Procedures (CAMP), Technical University of Munich(慕尼黑技术大学计算机辅助医疗程序中心) ; School of Biomedical Engineering, Faculty of Medicine, Dalian University of Technology(大连理工大学医学院生物医学工程学院) ; Affiliated Hospital of Chifeng University(赤峰大学附属医院) ; Center for Medical Imaging, Robotics, and Analytic Computing & Learning (MIRACLE), Suzhou Institute for Advanced Research, USTC, Suzhou, China(苏州先进研究院医学影像、机器人与分析计算与学习中心) ; Department of Biomedical Informatics, Harvard Medical School(哈佛医学院生物医学信息学系) ; The First Hospital and the College of Basic Medical Sciences of China Medical University(中国医科大学第一医院及基础医学科学学院) ; Munich Data Science Institute (MDSI)(慕尼黑数据科学研究所)
AI总结 提出Hireca病理基础模型和CytoMap可解释性模块,在10项生物标志物任务中多数领先,提供细胞级证据定位,实现透明可审查的生物标志物评估。